ESMO 2022 Conference Coverage


 

Lecture Summary - ESMO 2022 on the Additional Practice-Informing Adverse Event Patterns and Management in the KRYSTAL-1 Phase 2 Study: Adagrasib in KRASG12Cm NSCLC

10 views
September 27, 2022
Comments 0
Login to view comments. Click here to Login